TIMTOS: Innovative R&D, caring service

Mr. Samuel Chen is the Product Manager of Syntec. The company specialises in high performance and high efficiency PC-based CNC controller.

TIMTOS: Advanced design and innovative ability

Mr. John Chiang, Sales Manager of Detron Machine Co. Ltd., said that Detron is a professional manufacturer of CNC rotary tables.

Sub-Saharan Africa’s rice yield grows 30%

Post 2007 food crisis, rice production in sub-Saharan Africa picks up pace

TIMTOS: Pressure-increasing principle

Mr. Yang Chi-Ming is the person-in-charge of Herbert Enterprise Co. Ltd. He introduced the powerful pressure-increasing principle based on machine clamping the workpiece.

TIMTOS: Multi-functions and excellent quality

Mr. Allen Kao is the President of Sunrise Fluid Power Inc. The company specialises in hydraulic ironworkers, punching machines, bending machines, cylinders and other hydraulic equipment.

TIMTOS wraps up Taiwan's best & largest machining show

This event created show history by once again forging fresh records, and hosting 1,009 exhibitors from home and abroad to use 5,372 booths. Most of the exhibitors remain optimistic about this year’s prospect and posted good results in spite of the wheezy global economy.

India pharma pioneer K. Anji Reddy has died

The founder of generics giant, Dr. Reddy’s Laboratories, is credited with revolutionizing India’s pharmaceutical industry

Covidien names nominees to Mallinckrodt board

Mallinckrodt is preparing to become a separate, independently traded company in mid-2013

US budget cuts slash into fight vs superbugs

Antibiotic incentives through the U.S. Generating Antibiotic Incentives Now (GAIN) Act are not enough to tackle superbugs, say GlobalData analysts

Individualized HRT effective for menopause

Global Consensus Statement on Menopausal Hormone Therapy (HRT)

Aspirin may lower melanoma risk

US women aged 50 to 79 years who took more aspirin were less likely to develop melanoma skin cancer during the 12 years of follow up

Azithromycin side effects add to antibiotic woes

Azithromycin, currently marketed as Zithromax by Pfizer, has been linked to potentially fatal heart arrhythmia – making it more susceptible to competition from novel antibiotics